These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2519349)

  • 1. Intestinal drug absorption enhancement: an overview.
    van Hoogdalem EJ; de Boer AG; Breimer DD
    Pharmacol Ther; 1989; 44(3):407-43. PubMed ID: 2519349
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of non-steroidal anti-inflammatory drugs.
    Day RO; Graham GG; Williams KM
    Baillieres Clin Rheumatol; 1988 Aug; 2(2):363-93. PubMed ID: 3066499
    [No Abstract]   [Full Text] [Related]  

  • 3. Small intestinal mucosal protection mechanisms and their importance in rheumatology.
    O'Mahony S; Ferguson A
    Ann Rheum Dis; 1991 May; 50(5):331-6. PubMed ID: 2042991
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical tests for intestinal permeability: 'sweet' transition from clinical to basic physiology.
    Michel K; Zarogiannis SG
    Clin Exp Pharmacol Physiol; 2014 Feb; 41(2):105-6. PubMed ID: 24341961
    [No Abstract]   [Full Text] [Related]  

  • 5. In situ and in vivo efficacy of peroral absorption enhancers in rats and correlation to in vitro mechanistic studies.
    Sharma P; Varma MV; Chawla HP; Panchagnula R
    Farmaco; 2005; 60(11-12):874-83. PubMed ID: 16243320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of the Solubility and Intestinal Absorption of Curcumin by N-Acyl Taurates and Elucidation of the Absorption-Enhancing Mechanisms.
    Li X; Kawamura A; Sato Y; Morishita M; Kusamori K; Katsumi H; Sakane T; Yamamoto A
    Biol Pharm Bull; 2017; 40(12):2175-2182. PubMed ID: 29199240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hyperpermeability of the small intestine mucosa after prolonged application of non-steroidal anti-inflammatory drugs in patients with rheumatic diseases].
    Lebedeva VV; Gmoshinskiĭ IV; Mazo VK; Murav'ev IuV
    Eksp Klin Gastroenterol; 2008; (2):16-21. PubMed ID: 19148987
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on absorption of drugs. IV. Effects of rface active agents on intestinal absorption of drugs.
    Aoki M; Kamada A; Yata N; Kishimoto K; Mugino C
    Chem Pharm Bull (Tokyo); 1969 Jun; 17(6):1109-14. PubMed ID: 5804464
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of surfactants on transmucosal fluid movement and drug absorption from rat small intestine.
    Kitazawa S; Ishizu M; Kimura K
    Chem Pharm Bull (Tokyo); 1977 Apr; 25(4):590-600. PubMed ID: 880704
    [No Abstract]   [Full Text] [Related]  

  • 10. Cultured intestinal epithelial cell models.
    Hidalgo IJ
    Pharm Biotechnol; 1996; 8():35-50. PubMed ID: 8791803
    [No Abstract]   [Full Text] [Related]  

  • 11. Intestinal permeability enhancement: structure-activity and structure-toxicity relationships for nonylphenoxypolyoxyethylene surfactant permeability enhancers.
    Swenson ES; Milisen WB; Curatolo W
    Pharm Res; 1994 Oct; 11(10):1501-4. PubMed ID: 7855060
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhancement of intestinal absorption of poorly absorbed hydrophilic compounds by simultaneous use of mucolytic agent and non-ionic surfactant.
    Takatsuka S; Kitazawa T; Morita T; Horikiri Y; Yoshino H
    Eur J Pharm Biopharm; 2006 Jan; 62(1):52-8. PubMed ID: 16289777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between bioavailability and hypocholesterolemic activity of YM17E, an inhibitor of ACAT, in cholesterol-fed rats.
    Uchida T; Aoyama K; Watanabe T; Higuchi S
    Atherosclerosis; 1998 Mar; 137(1):97-106. PubMed ID: 9568741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of surfactant effects on drug absorption.
    Gibaldi M; Feldman S
    J Pharm Sci; 1970 May; 59(5):579-89. PubMed ID: 4911055
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of the gut in the amino acid economy of the host.
    Reeds PJ; Burrin DG; Stoll B; van Goudoever JB
    Nestle Nutr Workshop Ser Clin Perform Programme; 2000; 3():25-40; discussion 40-6. PubMed ID: 11490611
    [No Abstract]   [Full Text] [Related]  

  • 16. Modulation of ganciclovir intestinal absorption in presence of absorption enhancers.
    Shah P; Jogani V; Mishra P; Mishra AK; Bagchi T; Misra A
    J Pharm Sci; 2007 Oct; 96(10):2710-22. PubMed ID: 17680662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of food on the absorption of antimicrobial agents.
    Welling PG; Tse FL
    J Antimicrob Chemother; 1982 Jan; 9(1):7-27. PubMed ID: 7037731
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanism of drug absorption from micellar solution. II. Effect of polysorbate 80 on the absorption of micelle-free drugs.
    Kaneda A; Nishimura K; Muranishi S; Sezaki H
    Chem Pharm Bull (Tokyo); 1974 Mar; 22(3):523-8. PubMed ID: 4417750
    [No Abstract]   [Full Text] [Related]  

  • 19. Complexation with phosphatidyl choline as a strategy for absorption enhancement of boswellic acid.
    Sharma A; Gupta NK; Dixit VK
    Drug Deliv; 2010 Nov; 17(8):587-95. PubMed ID: 20624027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Making sense of gut contents.
    Dockray G
    Scand J Gastroenterol; 2003 May; 38(5):451-5. PubMed ID: 12795452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.